权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Novel functions of E-C coupling structural protein junctophilin-2 in the heart

E-C耦合结构蛋白junctophilin-2在心脏中的新功能

基本信息

批准号：
9199431
负责人：
Long-Sheng Song
金额：
$ 48.85万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-01-15 至 2019-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9199431
关键词：
Animal Model Binding Biochemistry CRISPR/Cas technology Calpain Cardiac Cardiac Myocytes Cardiac development Cardiomyopathies Cell Nucleus Cell Proliferation Cleaved cell Clustered Regularly Interspaced Short Palindromic Repeats Communication Complex Coupling Data Development Down-Regulation Echocardiography Electrophysiology (science)Event Future Gene Expression Gene Expression Profile Genes Genetic Transcription Goals Healthcare Systems Heart Heart Diseases Heart Hypertrophy Heart failure Hospitalization Human Imaging Techniques In Situ Knock-in Mouse Length Light Mediating Membrane Messenger RNA Modeling Molecular Molecular Biology Molecular Chaperones Muscle Cells N-terminal Nuclear Nuclear Localization Signal Pathogenesis Pathologic Patients Phenotype Physiological Pilot Projects Property Proteins Publishing Regulation Reporter Sarcoplasmic Reticulum Signal Transduction Stress Structural Protein System Technology Testing Therapeutic Transcriptional Regulation Transducers Transgenic Mice Transgenic Organisms Transmembrane Domain Ventricular base chromatin modification chromatin remodeling in situ imaging insight interdisciplinary approach junctophilin mouse model mutant novel novel therapeutic intervention promoter public health relevance response scaffold transcriptome

项目摘要

DESCRIPTION (provided by applicant): Junctophilin 2 (JP2) is a structural protein required for the formation of junctional couplings (i.e., cardiac dyads) between transverse (T)-tubule membrane and sarcoplasmic reticulum (SR) and is fundamental for local control of Ca2+-induced Ca2+ release and efficient contraction in ventricular myocytes during cardiac excitation- contraction (E-C) coupling. In animal models of heart failure, JP2 protein levels progressively decline, leading to T-tubule remodeling and loss of E-C coupling function. JP2 levels are also markedly reduced in human failing hearts. Our recently published and preliminary data demonstrate that JP2 is posttranslational regulated by calpain, a Ca2+-activated protease implicated in a variety of heart diseases. JP2 cleavage by calpain was originally hypothesized to underlie JP2 downregulation in failing hearts. In pilot studies, we made the novel and unexpected observation that an N-terminal JP2 cleavage fragment, termed "JP2NT," unlike full length JP2, is imported into nucleus, where it has a profound function in transcriptional reprogramming in cardiomyocytes. However, the (patho) physiological consequences of JP2NT nuclear localization and related molecular mechanisms are completely unknown. Based on these novel exciting preliminary findings, we hypothesize that, in response to stress, calpain-mediated cleavage of JP2 transforms JP2 from a structural protein into a transcriptional regulator that reprograms the transcriptional profile of damaged cardiomyocytes and represses the development of cardiac hypertrophy. This molecular event may be an important trigger for transcriptional remodeling, serving as an unappreciated protective mechanism under pathological conditions. We will test our hypothesis using a multidisciplinary approach, including multiple novels transgenic and CRISPR-based mouse models, molecular biology, biochemistry and a novel in situ confocal imaging technique developed by our lab. In Aim 1, we will explore the molecular mechanisms underlying JP2NT transcriptional regulation in cardiomyocytes, whereas Aim 2 will examine the patho(physiological) consequences of JP2NT in the heart. We anticipate the proposed studies will provide significant insights into the novel functions of JP2NT in membrane-to-nucleus signal transduction in the setting of cardiac stress and new insights into the cross- communication between cardiomyocyte structural remodeling and transcriptional remodeling in heart disease. This information will serve as a platform for the future development of novel heart failure therapeutics.